Mounjaro weight-loss injection pens should contain four doses, but some users are managing to get a fifth dose out of the devices. Experts are warning against this ...

“This approval enables access to the approved Mounjaro pen in a more convenient presentation of a month’s treatment, of one dose per week,” he added. It is to be used together with a reduced ...

Ozempic (semaglutide) is a brand-name injection pen used to treat type 2 diabetes. Meanwhile, Mounjaro (tirzepatide) is a brand-name subcutaneous injection pen also used to treat type 2 diabetes.

Ozempic (semaglutide) is a brand-name injection pen used to treat type 2 diabetes. Meanwhile, Mounjaro (tirzepatide) is a brand-name subcutaneous injection pen also used to treat type 2 diabetes.